AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 5 filers reported holding AMICUS THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76 | -77.8% | 6,244 | -77.1% | 0.03% | -81.8% |
| Q2 2023 | $343 | +183.5% | 27,318 | +176.4% | 0.18% | +120.7% |
| Q4 2022 | $121 | -99.6% | 9,882 | +197.8% | 0.08% | +182.8% |
| Q1 2022 | $32,000 | +88.2% | 3,318 | +128.2% | 0.03% | +20.8% |
| Q4 2021 | $17,000 | -63.0% | 1,454 | -52.7% | 0.02% | -54.7% |
| Q3 2021 | $46,000 | -87.0% | 3,072 | -91.6% | 0.05% | -85.1% |
| Q2 2021 | $353,000 | +146.9% | 36,594 | +492.3% | 0.36% | +123.9% |
| Q4 2020 | $143,000 | +240.5% | 6,178 | +107.6% | 0.16% | +278.6% |
| Q3 2020 | $42,000 | -58.8% | 2,976 | -60.4% | 0.04% | +7.7% |
| Q2 2020 | $102,000 | -28.7% | 7,520 | -51.5% | 0.04% | -83.3% |
| Q1 2020 | $143,000 | +28.8% | 15,495 | +36.5% | 0.23% | +82.0% |
| Q4 2019 | $111,000 | +98.2% | 11,348 | +155.1% | 0.13% | +300.0% |
| Q2 2019 | $56,000 | -1.8% | 4,448 | +6.0% | 0.03% | 0.0% |
| Q1 2019 | $57,000 | – | 4,196 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 22,790,134 | $182,777,000 | 6.12% |
| Perceptive Advisors | 24,609,700 | $197,369,000 | 5.32% |
| SECTORAL ASSET MANAGEMENT INC | 3,441,922 | $27,604,000 | 4.76% |
| Palo Alto Investors LP | 7,162,920 | $57,447,000 | 3.83% |
| Avoro Capital Advisors LLC | 11,100,000 | $89,022,000 | 3.71% |
| SPHERA FUNDS MANAGEMENT LTD. | 2,930,320 | $23,501,000 | 3.63% |
| Ghost Tree Capital, LLC | 1,705,000 | $13,674,000 | 3.48% |
| Novo Holdings A/S | 2,317,870 | $18,589,000 | 3.18% |
| Copernicus Capital Management, LLC | 335,000 | $2,687,000 | 2.50% |
| Boxer Capital, LLC | 2,325,000 | $18,647,000 | 1.35% |